The farnesoid receptor, a bile-acid-responsive transcription factor, decreases eNOS activity in cirrhosis, but does so through the Rho-kinase receptor in thioacetamide-induced cirrhosis, but not BDL-induced cirrhosis. This evidence concerns the gene NOS3 and Cirrhosis.